Li Y-N, Shi H-Z, Liang Q-L, Yang H-B, Huang G-M
Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China.
Lung Cancer. 2008 May;60(2):183-92. doi: 10.1016/j.lungcan.2007.09.024. Epub 2007 Nov 9.
Cytologic approaches such as pleural lavage cytology (PLC) are considered as possible aids to assessing prognosis of lung cancer patients. We aimed to comprehensively review the evidence for use of PLC to predict prognosis of lung cancer.
Fifteen studies, including 6391 patients, were found to be eligible for the present meta-analysis. A meta-analysis was done on the log hazard ratios and their variances in these studies.
Four studies dealt with pleural lavage before lung resection, six studies dealt with pleural lavage after lung resection, and five studies had PLC data from both before and after lung resection examination. For before lung resection studies, combined hazard ratios showed that positive PLC results had an unfavorable impact on survival: 3.96 (95% confidence interval 2.48-6.33), 4.55 (2.95-7.04), 5.00 (3.39-7.36), 5.67 (3.81-8.43), and 7.06 (5.04-9.90), for 1-, 2-, 3-, 4- and 5-year, respectively. For after lung resection studies, combined hazard ratios showed that positive PLC results had an unfavorable impact on survival: 6.02 (3.74-9.71), 6.64 (4.53-9.72), 7.06 (4.93-10.12), 7.29 (5.18-10.25), and 8.47 (6.12-11.73), for 1-, 2-, 3-, 4- and 5-year, respectively. Totally, the combined hazard ratio was 5.61 (3.98-7.90), showing a worse survival when PLC was positive. These findings could be overestimated because of publication and reporting bias.
PLC is a strong prognostic factor for survival in patients with lung cancer.
诸如胸腔灌洗细胞学检查(PLC)等细胞学方法被认为可能有助于评估肺癌患者的预后。我们旨在全面综述使用PLC预测肺癌预后的证据。
发现15项研究(共6391例患者)符合本荟萃分析的条件。对这些研究中的对数风险比及其方差进行了荟萃分析。
4项研究涉及肺切除术前的胸腔灌洗,6项研究涉及肺切除术后的胸腔灌洗,5项研究同时有肺切除术前和术后检查的PLC数据。对于肺切除术前的研究,合并风险比显示PLC结果为阳性对生存有不利影响:1年、2年、3年、4年和5年的风险比分别为3.96(95%置信区间2.48 - 6.33)、4.55(2.95 - 7.04)、5.00(3.39 - 7.36)、5.67(3.81 - 8.43)和7.06(5.04 - 9.90)。对于肺切除术后的研究,合并风险比显示PLC结果为阳性对生存有不利影响:1年、2年、3年、4年和5年的风险比分别为6.02(3.74 - 9.71)、6.64(4.53 - 9.72)、7.06(4.93 - 10.12)、7.29(5.18 - 10.25)和8.47(6.12 - 11.73)。总体而言,合并风险比为5.61(3.98 - 7.90),表明PLC为阳性时生存情况更差。由于发表和报告偏倚,这些结果可能被高估。
PLC是肺癌患者生存的一个强有力的预后因素。